Armistice Capital »

Golar Lng shares owned by Armistice Capital

Quarter-by-quarter ownership of Golar Lng (GLNG) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Golar Lng

Tip: Access up to 7 years of quarterly data

All positions including Golar Lng held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Golar Lng by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $237k 4.8k 49.84

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Golar Lng

Naria
Rubric Capital Management
BlackRock
Sachem Head Capital Management
Morgan Stanley
Susquehanna International
Invesco
Rokos Capital Management
State Street Corporation
Wolf Hill Capital Management
Fil
Geode Capital Management
Two Seas Capital
Steinberg Asset Management
Two Sigma Investments

View all funds holding Golar Lng